Neil E. Klutman
Impact in
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- Infectious Encephalopathies and Encephalitis
- Amoebic Infections and Treatments
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 1
-
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Collin D. Freeman (3 shared papers)Kenneth C. Lamp (3 shared papers)Melinda K. Lacy (4 shared papers)Rebecca T. Horvat (2 shared papers)Christopher M. Riley (2 shared papers)Colleen M. Culley (1 shared paper)Brian Edwards (1 shared paper)Dennis Grauer (1 shared paper)
- Journals
- American Journal of Health-System Pharmacy (4 papers)Annals of Pharmacotherapy (2 papers)Journal of Clinical Microbiology (1 paper)Clinical Pharmacokinetics (1 paper)Drugs (1 paper)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Neil E. Klutman
14 papers receiving 799 citations
Peers
Comparison fields: 5 of 110
- Applied Microbiology and Biotechnology 34
- Infectious Diseases 236
- Microbiology 74
- Parasitology 73
- Molecular Medicine 40
Countries citing papers authored by Neil E. Klutman
This map shows the geographic impact of Neil E. Klutman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Klutman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Klutman more than expected).
Fields of papers citing papers by Neil E. Klutman
This network shows the impact of papers produced by Neil E. Klutman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Klutman. The network helps show where Neil E. Klutman may publish in the future.
Co-authors
The 16 scholars most cited alongside Neil E. Klutman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 384 | |
| 2 | 1999 | 286 | |
| 3 | 2001 | 36 | |
| 4 | 2003 | 27 | |
| 5 | 1990 | 24 | |
| 6 | 2004 | 20 | |
| 7 | 1998 | 12 | |
| 8 | 1993 | 11 | |
| 9 | 1992 | 9 | |
| 10 | 1998 | 9 | |
| 11 | 1995 | 6 | |
| 12 | 1991 | 5 | |
| 13 | 1997 | 3 | |
| 14 | Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles. | 1996 | 2 |
About Neil E. Klutman
Neil E. Klutman is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Molecular Medicine and Surgery, having authored 14 papers that have together received 834 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (3 papers), Pneumonia and Respiratory Infections (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Pharmaceutical studies and practices (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Phenothiazines and Benzothiazines Synthesis and Activities (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (34 citations), Infectious Diseases (236 citations), Microbiology (74 citations), Parasitology (73 citations) and Molecular Medicine (40 citations). Neil E. Klutman has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Collin D. Freeman, Kenneth C. Lamp, Melinda K. Lacy, Rebecca T. Horvat, Christopher M. Riley, Colleen M. Culley, Brian Edwards, Dennis Grauer, Antonia Zapantis and Suzanne Meeves. Their work appears in journals such as American Journal of Health-System Pharmacy, Annals of Pharmacotherapy, Journal of Clinical Microbiology, Clinical Pharmacokinetics and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.